Summary
- Current Price
- As of today, SNN price is $29.81, down -1.00% on
- Current Price All-Time High
- SNN price is currently -42.96% below its historical high of $52.26 set on
- Market Cap
- SNN current market cap is $12B, down -23.58% year-over-year
- Revenue
- SNN current annual revenue is $6.18B, up +6.30% year-over-year
- Next Earnings
- The next earnings release for SNN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Smith & Nephew plc |
| Ticker | NYSE: SNN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | smith-nephew.com |
| Employees | 17,349 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $29.81 | |
| Price, 1D Change | -1.00% | |
| Market Cap | $12B | |
| TTM Dividend Yield | 2.62% | |
| PE Ratio | - | |
| Beta | 0.40 | |
| Revenue | $6.18B | |
| Revenue, 1Y Change | +6.30% | |
| EPS | $1.44 | |
| EPS, 1Y Change | +52.52% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.48 | |
| Next Ex-Dividend | $0.31 | |
| Last Split | 5:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $1.44 | |
| EPS Estimate | $2.19 | |
| EPS Est. Change | +52.59% | |
| Revenue | $6.18B | |
| Revenue Estimate | $6.50B | |
| Revenue Est. Change | +5.19% | |
| Current Price | $29.81 | |
| Price Target | $34.57 | - |
| Price Tgt. Change | +15.97% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.39 | $0.94 | -32.45% | |
| $1.61 | $1.44 | -11.12% | |
| $2.19 | N/A | +52.59% | |
| $2.43 | N/A | +69.11% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.77B | $5.81B | +0.66% | |
| $6.14B | $6.18B | +0.69% | |
| $6.50B | N/A | +5.19% | |
| $6.86B | N/A | +11.04% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -18.60% | |
| Price, 3Y | +6.31% | |
| Market Cap, 1Y | -23.58% | |
| Market Cap, 3Y | -0.19% | |
| Revenue, 1Y | +6.30% | |
| Revenue, 3Y | +18.47% | |
| EPS, 1Y | +52.52% | |
| EPS, 3Y | +180.92% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $29.81 | |
| SMA 200 | $32.42 | |
| SMA 50 | $30.47 | |
| EMA 200 | $31.69 | |
| EMA 50 | $30.61 | |
| MACD | -$0.18 | |
| Beta | 0.40 | |
| ATR | $0.72 | |
| 14-Day RSI | 44.38 | |
| 10-Day Volatility | 31.76% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.48 | |
| Upcoming | $0.31 | |
| Dividend Yield | 2.56% | |
| Total Dividend | $0.76 | |
| $330.77M | ||
| 52.80% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $6.18B | |
| EPS | $1.44 | |
| Gross Profit | $4.20B | |
| Gross Margin | 68.01% | |
| Operating Income | $1.01B | |
| Operating Margin | 16.27% | |
| Net Income | $626.46M | |
| Net Margin | 10.14% | |
| EBITDA | $1.58B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.63 | |
| 2.57 | ||
| 1.25 | ||
| - | ||
| - | ||
| 3.36 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 9.62 | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $5.29B | |
| $557.00M | ||
| $10.46B | ||
| $4.10B | ||
| $5.17B | ||
| $1.60B | ||
| Total Debt | $3.33B | |
| $150.00M | ||
| $1.16B |
Expenses
| Metric | Value | Date |
|---|---|---|
| $5.55B | ||
| $3.20B | ||
| $2.04B | ||
| $0.00 | ||
| $574.34M | ||
| $0.00 | ||
| $154.36M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $1.29B | ||
| -$406.95M | ||
| -$957.23M | ||
| Capex | $434.01M | |
| $853.99M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| Barclays | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| Bernstein | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| UBS | → |
Analyst sentiment
Institutional ownership
Screeners with SNN
FAQ
- What is the ticker symbol for Smith & Nephew plc?
- The ticker symbol for Smith & Nephew plc is NYSE:SNN
- Does Smith & Nephew plc pay dividends?
- Yes, Smith & Nephew plc pays dividends. The last payment was $0.48, with an ex-dividend date on March 27, 2026
- What sector is Smith & Nephew plc in?
- Smith & Nephew plc is in the Healthcare sector
- What industry is Smith & Nephew plc in?
- Smith & Nephew plc is in the Medical Devices industry
- What country is Smith & Nephew plc based in?
- Smith & Nephew plc is headquartered in United Kingdom
- When did Smith & Nephew plc go public?
- Smith & Nephew plc initial public offering (IPO) was on November 16, 1999
- Is Smith & Nephew plc in the S&P 500?
- No, Smith & Nephew plc is not included in the S&P 500 index
- Is Smith & Nephew plc in the NASDAQ 100?
- No, Smith & Nephew plc is not included in the NASDAQ 100 index
- Is Smith & Nephew plc in the Dow Jones?
- No, Smith & Nephew plc is not included in the Dow Jones index
- When was Smith & Nephew plc last earnings report?
- Smith & Nephew plc's most recent earnings report was on August 4, 2026
- When does Smith & Nephew plc report earnings?
- The next expected earnings date for Smith & Nephew plc is March 1, 2027
Data Sources & References
- SNN Official Website www.smith-nephew.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/845982/000165495426001697/0001654954-26-001697-index.htm
- SNN Profile on Yahoo Finance finance.yahoo.com/quote/SNN
- SNN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/snn
